The pathophysiology of COVID-19, including severe or moderate disease, involves depletion of CD8+ MAIT cells, a fact that could be exploited in future studies to develop a better understanding of disease pathogenesis or develop interventional novel strategies. The gene discussed is CD8A; the disease is COVID-19.